+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 14Years +
All Genders
ID07659769

International Observational Study on Healthcare and Quality of Life in Hidradenitis Suppurativa Patients

Led by Julia Tatjana Maul · Updated on 2026-09-28

9600

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the Global Healthcare Study on Hidradenitis Suppurativa GHSHS, an international observational study led by the University of Zurich. The study aims to understand healthcare access, treatment patterns, disease severity, and quality of life in patients with hidradenitis suppurativa by collecting standardized clinical data. This research seeks to identify differences in healthcare delivery and outcomes across various healthcare systems. The study uses both retrospective and prospective data collection from routine clinical care and medical records starting from January 2020 until the study ends. There are no investigational treatments instead, the study observes patients during their usual care. Clinical data includes disease severity assessments and quality of life evaluations over time. Participants will have data collected from their routine medical visits at baseline and follow-up every 6 to 12 months for up to 5 years. Researchers will measure disease severity using tools like the International Hidradenitis Suppurativa Severity Score System IHS4 and other scoring systems, along with patient-reported pain and quality of life assessments. The study monitors participants health status over a long period without altering their care.

CONDITIONS

Brief Title

Global Healthcare Study on Hidradenitis Suppurativa

Research Team

J

Julia-Tatjana Maul, Prof. Dr. med.

J

Johannes Didaskalu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here